Patents by Inventor Kwok Pui Fung

Kwok Pui Fung has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11690810
    Abstract: The present invention resides in the discovery that combined use of kuraridin (or any one of its analogs) and epicatechin gallate (ECG) can provide heightened level of antimicrobial activity, especially for the suppression of bacteria of the Staphylococcus aureus and Staphylococcal species. Compositions, kits, and methods for the combination use are disclosed.
    Type: Grant
    Filed: November 14, 2019
    Date of Patent: July 4, 2023
    Assignee: The Chinese University of Hong Kong
    Inventors: Margaret Ip, Kwok Pui Fung, Ping Chung Leung, Clara Bik San Lau, Quan Bin Han, Chung Lap Chan, Chit Tsui, Quande Wang
  • Publication number: 20200155641
    Abstract: The present invention resides in the discovery that combined use of kuraridin (or any one of its analogs) and epicatechin gallate (ECG) can provide heightened level of antimicrobial activity, especially for the suppression of bacteria of the Staphylococcus aureus and Staphylococcal species. Compositions, kits, and methods for the combination use are disclosed.
    Type: Application
    Filed: November 14, 2019
    Publication date: May 21, 2020
    Inventors: MARGARET IP, Kwok Pui Fung, Ping Chung Leung, Clara Bik San Lau, Quan Bin Han, Chung Lap Chan, Chit TSUI, Quande Wang
  • Publication number: 20080286756
    Abstract: The present invention relates to the fields of immunochemistry and pharmacology. Methods and compositions are described for the diagnosis and treatment of SARS CoV infection. More specifically, the application discloses nucleic acids and peptides of the spike glycoprotein of SARS CoV that provide prognostic and therapeutic compositions in treatment of individuals contracting, or in danger of contracting SARS CoV. The peptides of the invention are also useful in producing antibodies against the SARS CoV glycoprotein.
    Type: Application
    Filed: April 3, 2008
    Publication date: November 20, 2008
    Applicant: THE CHINESE UNIVERSITY OF HONG KONG
    Inventors: Kwok Wing TSUI, Kwok Pui Fung, Mary Miu Yee Waye, Yuk Ming Dennis Lo, Siu Chung Stephen Chim, Wai Kwun Rossa Chiu, Siu Lun John Tam, Kay Sheung Paul Chan
  • Patent number: 7371525
    Abstract: The present invention relates to the fields of immunochemistry and pharmacology. Methods and compositions are described for the diagnosis and treatment of SARS CoV infection. More specifically, the application discloses nucleic acids and peptides of the spike glycoprotein of SARS CoV that provide prognostic and therapeutic compositions in treatment of individuals contracting, or in danger of contracting SARS CoV. The peptides of the invention are also useful in producing antibodies against the SARS CoV glycoprotein.
    Type: Grant
    Filed: July 28, 2004
    Date of Patent: May 13, 2008
    Assignee: The Chinese University of Hong Kong
    Inventors: Kwok Wing Tsui, Siu Chung Stephen Chim, Mary Miu Yee Waye, Kwok Pui Fung, Yuk Ming Dennis Lo, Wai Kwun Rossa Chiu, Siu Lun John Tam, Kay Sheung Paul Chan
  • Publication number: 20040191334
    Abstract: This present invention provides a new use of tanshinone derivatives as acetylcholinesterase inhibitors and in treating diseases associated with the depletion of acetylcholine such as cognitive impairment including Alzheimer's disease, insomnia, vascular dementia, memory loss, disorders of attention and other sleeping disorders. The active compounds commonly found in the root of Salvia genus, particularly Salvia miltiorrhiza, Danshen.
    Type: Application
    Filed: March 24, 2003
    Publication date: September 30, 2004
    Inventors: Pang-Chui Shaw, Michelle Tsz-Wan Ho, Kwok-Pui Fung, David Chi-Cheong Wan